It is an inhibitor of type 2 sodium glucose cotransporter 2 (sglt-2). Sglt-2 inhibitor is a new hypoglycemic drug. It mainly reduces the reabsorption of glucose by kidney and increases the excretion of glucose in urine by inhibiting sglt-2 expressed in urine, so as to reduce the plasma glucose level. Its hypoglycemic effect does not depend on β Cell function Empagliflozin, sold under the trade name Jardiance among others, is a medication used together with diet and exercise to treat type 2 diabetes. It is less preferred than metformin and sulfonylureas. It may be used together with other medications such as metformin It is not recommended for type 1 diabetes. It is taken by mouth.

CAS NO:25316-40-9

EC NO:246-818-3

Molecular Formula:C₂₇H₃₀ClNO₁₁

Molecular Weight:579.9802

Synonyms:;Doxorubicin, HCl;(8s-cis)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride;(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxyhexopyranoside hydrochloride (1:1);(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside hydrochloride (1:1);Doxorubicin HCL;Doxourbicin HCl;

Molecular Structure: